Patents by Inventor Frances Joanne Morling

Frances Joanne Morling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7846429
    Abstract: Disclosed are compositions comprising a recombinant nucleic acid vector including a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface, and a host cell containing the recombinant vector and expressing the syncytium inducing polypeptide on its cell surface, the vectors and resultant host cells expressing the syncytium inducing polypeptide being useful for selective elimination of unwanted cells.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: December 7, 2010
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Stephen James Russell, Frances Joanne Morling, Adele Kay Fielding, Francois-Loic Cosset, Roberto Cattaneo
  • Publication number: 20080226610
    Abstract: Disclosed are compositions comprising a recombinant nucleic acid vector including a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface, and a host cell containing the recombinant vector and expressing the syncytium inducing polypeptide on its cell surface, the vectors and resultant host cells expressing the syncytium inducing polypeptide being useful for selective elimination of unwanted cells.
    Type: Application
    Filed: October 31, 2007
    Publication date: September 18, 2008
    Inventors: Stephen James Russell, Frances Joanne Morling, Adele Kay Fielding, Francis-Loic Cosset, Roberto Cattaneo
  • Publication number: 20080227740
    Abstract: Disclosed are compositions comprising a recombinant nucleic acid vector including a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface, and a host cell containing the recombinant vector and expressing the syncytium inducing polypeptide on its cell surface, the vectors and resultant host cells expressing the syncytium inducing polypeptide being useful for selective elimination of unwanted cells.
    Type: Application
    Filed: October 31, 2007
    Publication date: September 18, 2008
    Inventors: Stephen James Russell, Frances Joanne Morling, Adele Kay Fielding, Francois-Loic Cosset, Roberto Cattaneo
  • Publication number: 20080171027
    Abstract: Disclosed are compositions comprising a recombinant nucleic acid vector including a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface, and a host cell containing the recombinant vector and expressing the syncytium inducing polypeptide on its cell surface, the vectors and resultant host cells expressing the syncytium inducing polypeptide being useful for selective elimination of unwanted cells.
    Type: Application
    Filed: October 31, 2007
    Publication date: July 17, 2008
    Inventors: Stephen James Russell, Frances Joanne Morling, Adele Kay Fielding, Francois-Loic Cosset, Roberto Cattaneo
  • Publication number: 20080171026
    Abstract: Disclosed are compositions comprising a recombinant nucleic acid vector including a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface, and a host cell containing the recombinant vector and expressing the syncytium inducing polypeptide on its cell surface, the vectors and resultant host cells expressing the syncytium inducing polypeptide being useful for selective elimination of unwanted cells.
    Type: Application
    Filed: October 31, 2007
    Publication date: July 17, 2008
    Inventors: Stephen James Russell, Frances Joanne Morling, Adele Kay Fielding, Francis-Loic Cosset, Roberto Cattaneo
  • Patent number: 7317004
    Abstract: Disclosed are compositions comprising a recombinant nucleic acid vector including a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface, and a host cell containing the recombinant vector and expressing the syncytium inducing polypeptide on its cell surface, the vectors and resultant host cells expressing the syncytium inducing polypeptide being useful for selective elimination of unwanted cells.
    Type: Grant
    Filed: August 18, 2005
    Date of Patent: January 8, 2008
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Stephen James Russell, Frances Joanne Morling, Adele Kay Fielding, Francois-Loic Cosset, Roberto Cattaneo
  • Patent number: 7314868
    Abstract: Disclosed are compositions comprising a recombinant nucleic acid vector including a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface, and a host cell containing the recombinant vector and expressing the syncytium inducing polypeptide on its cell surface, the vectors and resultant host cells expressing the syncytium inducing polypeptide being useful for selective elimination of unwanted cells.
    Type: Grant
    Filed: December 10, 2003
    Date of Patent: January 1, 2008
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Stephen James Russell, Frances Joanne Morling, Adele Kay Fielding, Francois-Loic Cosset, Roberto Cattaneo
  • Publication number: 20040253214
    Abstract: Disclosed are compositions comprising a recombinant nucleic acid vector including a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface, and a host cell containing the recombinant vector and expressing the syncytium inducing polypeptide on its cell surface, the vectors and resultant host cells expressing the syncytium inducing polypeptide being useful for selective elimination of unwanted cells,
    Type: Application
    Filed: December 10, 2003
    Publication date: December 16, 2004
    Applicant: Mayo Foundation For Medical Education and Research, a Minnesota corporation
    Inventors: Stephen James Russell, Frances Joanne Morling, Adele Kay Fielding, Francois-Loic Cosset, Roberto Cattaneo
  • Patent number: 6750206
    Abstract: Disclosed are compositions comprising a recombinant nucleic acid vector including a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface, and a host cell containing the recombinant vector and expressing the syncytium inducing polypeptide on its cell surface, the vectors and resultant host cells expressing the syncytium inducing polypeptide being useful for selective elimination of unwanted cells.
    Type: Grant
    Filed: April 30, 1998
    Date of Patent: June 15, 2004
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Stephen James Russell, Frances Joanne Morling, Adele Kay Fielding, Francois-Loic Cosset, Roberto Cattaneo
  • Publication number: 20030095947
    Abstract: Compositions and Methods for Elimination of Unwanted Cells Disclosed are compositions comprising a recombinant nucleic acid vector including a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface, and a host cell containing the recombinant vector and expressing the syncytium inducing polypeptide on its cell surface, the vectors and resultant host cells expressing the syncytium inducing polypeptide being useful for selective elimination of unwanted cells.
    Type: Application
    Filed: April 30, 1998
    Publication date: May 22, 2003
    Inventors: STEPHEN JAMES RUSSELL, FRANCES JOANNE MORLING, ADELE KAY FIELDING, FRANCOIS-LOIC COSSET, ROBERTO CATTANEO
  • Patent number: 6270761
    Abstract: Disclosed are various compositions for use in the delivery of nucleic acid to a target cell including: a composition comprising a calcium salt in particulate form, the nucleic acid to be delivered, and one or more further components to enhance the efficiency of delivery of the nucleic acid to a target cell, the nucleic acid and the one or more further components being complexed with the particulate calcium salt; and methods of delivering a nucleic acid to a target cell.
    Type: Grant
    Filed: June 29, 1998
    Date of Patent: August 7, 2001
    Assignee: Cambridge Drug Discovery Holdings, LTD
    Inventors: Stephen James Russell, Frances Joanne Morling
  • Patent number: 5858743
    Abstract: The invention provides a recombinant viral particle for delivering a nucleic acid to mammalian cells, the particle comprising an MLV-env protein that binds to an MLV-env receptor expressed on the surface of a target cell so as to cause infection thereof, and a surface-exposed EGF that binds to an EGF receptor generally not expressed on the surface of the target cell, but expressed on non-target cells that also express the MLV-env receptor, such that binding of the viral particle to the EGF receptor via EGF inhibits infection of the non-target cell by the viral particle.
    Type: Grant
    Filed: June 9, 1997
    Date of Patent: January 12, 1999
    Assignee: Medical Research Council
    Inventors: Stephen James Russell, Francois-Loic Cosset, Frances Joanne Morling, Robin Anthony Weiss, Mary Katharine L. Collins